Key result
Race- and sex-specific models using routine variables demonstrate good discrimination for incident HFpEF and HFrEF.
Why the study?
The study aimed to develop the first race-specific and sex-specific risk prediction models for incident HFpEF and HFrEF.
Cohort (n=1,849,845)
Yes
Race- and sex-specific risk prediction models using routine clinical variables demonstrated good discrimination for predicting incident HFpEF and HFrEF over a median 11.1 years of follow-up.
AIMS: This study aims to develop the first race-specific and sex-specific risk prediction models for heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF). METHODS AND RESULTS: We created a cohort of 1.8 million individuals who had an outpatient clinic visit between 2002 and 2007 within the Veterans Affairs (VA) Healthcare System and obtained information on HFpEF, HFrEF, and several risk factors from electronic health records (EHR). Variables were selected for the risk prediction models in a 'derivation cohort' that consisted of individuals with baseline date in 2002, 2003, or 2004 using a forward stepwise selection based on a change in C-index threshold. Discrimination and calibration were assessed in the remaining participants (internal 'validation cohort'). A total of 66 831 individuals developed HFpEF, and 92 233 developed HFrEF (52 679 and 71 463 in the derivation cohort) over a median of 11.1 years of follow-up. The HFpEF risk prediction model included age, diabetes, BMI, COPD, previous MI, antihypertensive treatment, SBP, smoking status, atrial fibrillation, and estimated glomerular filtration rate (eGFR), while the HFrEF model additionally included previous CAD. For the HFpEF model, C-indices were 0.74 (SE = 0.002) for white men, 0.76 (0.005) for black men, 0.79 (0.015) for white women, and 0.77 (0.026) for black women, compared with 0.72 (0.002), 0.72 (0.004), 0.77 (0.017), and 0.75 (0.028), respectively, for the HFrEF model. These risk prediction models were generally well calibrated in each race-specific and sex-specific stratum of the validation cohort. CONCLUSIONS: Our race-specific and sex-specific risk prediction models, which used easily obtainable clinical variables, can be a useful tool to implement preventive strategies or subtype-specific prevention trials in the nine million users of the VA healthcare system and the general population after external validation.
No takes yet. Share an insight, caveat, or question.
Gaziano et al. (2021) conducted a cohort in Incident heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF) (n=1,849,845). Race-specific and sex-specific risk prediction models was evaluated on Incident HFpEF and HFrEF. Race-specific and sex-specific risk prediction models using routine clinical variables demonstrated good discrimination for incident HFpEF and HFrEF, with C-indices ranging from 0.72 to 0.79.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: